Star’s Death: Counselor’s SHOCKING SENTENCE REVEALED

Interior of a courtroom featuring a judges bench and American flag

A licensed drug addiction counselor who supplied the ketamine killing Matthew Perry receives just two years in prison, exposing flaws in federal sentencing for deadly drug conspiracies.[1][2][3]

Story Snapshot

Erik Fleming, a licensed drug addiction counselor, pleaded guilty to conspiracy and distribution of ketamine resulting in Perry’s death.[1][2]
Fleming brokered deals for 50-51 vials from Jasveen Sangha to Perry’s assistant Kenneth Iwamasa, marking up prices for profit.[1][2][3]
Federal court sentenced Fleming to two years in prison plus three years supervised release on May 13, 2026, far below the 25-year maximum.[1][2]
Sangha, the “Ketamine Queen,” got 15 years; two doctors faced lighter penalties in the five-person conspiracy.[3]
Fleming’s cooperation and counselor background highlight sentencing disparities in celebrity overdose cases.[1][3]

Fleming’s Role in the Ketamine Conspiracy

Erik Fleming, 56, a licensed drug addiction counselor from Hawthorne, California, pleaded guilty on August 8, 2024, to one count of conspiracy to distribute ketamine and one count of distribution of ketamine resulting in death.[1][2] Federal prosecutors in the Central District of California detailed Fleming’s actions as a middleman. He connected Perry’s live-in personal assistant, Kenneth Iwamasa, with Jasveen Sangha after learning Perry sought illicit ketamine.[1][3] Fleming coordinated two transactions, delivering 50-51 vials of unmarked, non-medical grade ketamine in October 2023 for $11,000 in cash.[2][3]

Prosecutors emphasized Fleming’s knowledge of Perry’s long-documented addiction history, well-publicized in his memoir and media.[1][3] Despite this, Fleming marked up vial prices from Sangha’s $160 to $220 each, profiting from the sales.[1] On October 28, 2023, Iwamasa injected Perry with at least three doses from this batch, leading to the actor’s death at age 54 in his jacuzzi.[1][2][3] The U.S. Department of Justice labeled it a conspiracy among five individuals.[3]

Sentencing Details and Judicial Decision

U.S. District Judge Sherilyn Peace Garnett sentenced Fleming to two years in federal prison on May 13, 2026, plus three years of supervised release and mental health treatment.[1][2] Prosecutors sought 30 months, citing Fleming’s “profit-seeking behavior and reckless distribution” of dubious drugs.[1][2] Fleming’s defense requested three months plus release, arguing three small transactions yielded under $2,000 in logistical fees amid personal relapse.[2] The two-year term reflects a downward variance from the 25-year maximum.[1]

Judge Garnett noted Fleming’s major role in supplying the ketamine that caused Perry’s death but accepted mitigating factors.[2] Fleming was the first to cooperate with investigators, potentially aiding cases against co-defendants.[1][3] This cooperation likely contributed to his reduced sentence, consistent with federal patterns where minor-role participants average 24-36 months.[3]

Co-Defendants and Broader Case Context

Jasveen Sangha, 42, the North Hollywood dealer dubbed the “Ketamine Queen,” received 180 months in April 2026 for her role.[3] Salvador Plasencia, a Santa Monica doctor known as “Dr. P,” got 30 months after pleading guilty to four counts of ketamine distribution and surrendering his license.[3] Mark Chavez, a former ketamine clinic operator, faced eight months of home confinement.[1] Iwamasa, Perry’s assistant, pleaded guilty and awaits sentencing on May 27, 2026.[1]

Matthew Perry ketamine supplier Erik Fleming gets two years in prison

Federal case maps network of counsellors doctors and dealers, celebrity overdose ends in routine sentencing mathhttps://t.co/cLPGTNbgp3

A federal judge in Los Angeles has sentenced Erik Fleming, a drug…

— Corax (@coraxnews) May 13, 2026

This case mirrors federal trends in overdose prosecutions, where enablers like Fleming receive lighter terms than primary suppliers.[3] U.S. Sentencing Commission data shows 68% of death-resulting drug cases since 2018 involve downward variances for cooperation.[3] Conservatives question if celebrity status influences such disparities, urging stricter accountability to deter deadly distribution networks amid the fentanyl and designer drug crises ravaging families.[3]